Saga Pharmaceuticals believe that GCC, with a per capita income of USD 7,000 (Dh 25,711) & growing exponentially year on year and with a population growing at 4% every year, has tremendous potential o
Dayarn Pharma is a partner of DuBiotech and is active in the following segments: - Smaller pharmaceutical companies not yet present in the region but wishing to access Middle East markets. - Multin
Dubai Biotechnology & Research Park, Diagnostika is a specialist lab offering advanced, reference tests for improved and accurate diagnosis of complex conditions. The laboratory testing services cover
Boston BioCapital supports the providers of growth capital in the fields of healthcare, pharmaceutical, and life sciences as well as limited partners interested in this space in connecting with each o
UAE based biotechnology company, offering a general medical diagnostic tests including DNA Tests, cancer screening tests, paternity tests, genetic tests, cytogenetic test, genomic profiling and more.
